Search
FR
Print page

Zoledronic Acid For Injection

  • Generic name

    zoledronic acid monohydrate

  • Brand reference

    Zometa®

  • Strength

    0.8 mg/mL

  • DIN

    02407639

  • Therapeutic class

    Bone Metabolism Regulator

  • Therapeutic area

    Bone Metabolism Regulator

  • Package size

    Vial 5 mL

  • Product code

    86818-0005

  • UPC

    068510179456

  • Generic name:

    zoledronic acid monohydrate

  • Brand reference:

    Zometa®

  • Product code:

    86818-0005

  • Strength

    0.8 mg/mL

  • DIN

    02407639

  • UPC:

    068510179456

  • Therapeutic class

    Bone Metabolism Regulator

  • Therapeutic area:

    Bone Metabolism Regulator

  • Package size:

    Vial 5 mL

Composition

Active ingredient

zoledronic acid monohydrate


Non-medicinal ingredients

220 mg mannitol per vial, as tonicity agent and 24 mg sodium citrate dihydrate per vial, as buffering agent and water for injection

Product characteristics

  • Dosage form

    solution for injection

  • Shape

  • Marking 1

  • Marking 2

  • Colour

  • Secondary colour

  • Scored

  • Flavour

  • Gluten

    currently not available

  • Latex

    no

Disclaimers

All information about raw materials and/or allergen information for Teva Canada’s products is obtained from our suppliers and/or third-party affiliates and is based on their records.

Please be advised that the Medical Information department is not always notified of change in third-party affiliates and/or change in suppliers of the active and inactive ingredients that may occur over time, and all information provided herein is based on our last records on file.

Our manufacturing sites are not certified gluten-free. Raw materials and finished products are not tested for the presence of gluten. Therefore, the presence of trace amounts of gluten in the raw materials and in the finished products cannot be excluded.

"Latex" refers to NATURAL RUBBER LATEX. We cannot guarantee that there is no latex in the outer packaging, or that the medication or packaging haven’t come into contact with latex at any point during the manufacturing process; however, this is very unlikely due to the strict GMP procedures that are in place in all of our manufacturing facilities. Employees in the manufacturing and/or packaging facilities may be wearing latex gloves.

Product monograph/consumer information leaflet


View monograph

Notice

We are modifying our product names to align with our corporate name change. Accordingly, please expect product monographs to contain the “Novo-”, “ratio-”, “ACT”, "CO" prefix or the new “Teva” prefix. These prefixes may be used interchangeably on the website.

Should you have any questions about our product names or our corporate name change, please do not hesitate to contact us. Our Customer Care department can be reached at 1-800-268-4127 regarding your inquiry.

Caution: You are about to leave the TevaCanada.com website. Click "Continue" to certify that you have read the following communication and view the selected website.

Links to websites not under the control of Teva Canada, including links to social media sites, are provided solely for the convenience of visitors to our website. Teva Canada is not responsible for the accuracy, timeliness, completeness, appropriateness or accuracy of the content of these websites and does not endorse or recommend opinions, ideas, products , the information or the content of these sites. Teva Canada hereby disclaims all liability for all information, materials, products or services without exception that are displayed, offered or made available to visitors of a third party website. As third parties may have a privacy or computer security policy that differs from Teva Canada, please refer to the privacy or security policies of those third parties when accessing their respective websites.